Amazing we are still at $2 per share when you consider the value of ASTX if FDA approves next month and then the EU. How can this not go up at least 50% on the day it is approved? Oh yea, we are talking M@$@#$ here. The Street HATES him.
Approval would offset any lost revenues when Dacogen goes generic for MDS even though that has not been seen from Vidaza sales I believe.